A nurse is assisting with the care of a client who has hypertension and chronic kidney disease. The client is scheduled for hemodialysis. Which of the following actions should the nurse plan to take while caring for this client? (Select all that apply.)
Obtain the client’s weight.
Verify the glomerular filtration rate.
Check the graft site for a palpable thrill.
Document vital signs.
Administer a sedative to the client.
Correct Answer : A,C,D
The correct answers are Choices A, C, and D.
Choice A rationale: Obtaining the client's weight is important before and after hemodialysis to assess fluid removal and monitor the patient's fluid balance.
Choice B rationale: Verifying the glomerular filtration rate (GFR) is not necessary immediately before hemodialysis. GFR is typically assessed periodically to monitor kidney function but is not required for each dialysis session.
Choice C rationale: Checking the graft site for a palpable thrill is essential to ensure the arteriovenous (AV) fistula or graft is functioning properly. The thrill indicates that blood is flowing through the access site.
Choice D rationale: Documenting vital signs is crucial before, during, and after hemodialysis to monitor the client's hemodynamic status and detect any complications.
Choice E rationale: Administering a sedative is not a routine part of hemodialysis care. Sedatives may be prescribed for specific situations, but it is not standard practice.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A rationale
Phenazopyridine hydrochloride does not turn the urine purple. This color change is not associated with the medication.
Choice B rationale
Phenazopyridine hydrochloride turns the urine orange. This is a common and expected side effect of the medication and is harmless.
Choice C rationale
Phenazopyridine hydrochloride does not turn the urine blue. This color change is not associated with the medication.
Choice D rationale
Phenazopyridine hydrochloride does not turn the urine green. This color change is not associated with the medication.
Correct Answer is B
Explanation
Choice A rationale
Oseltamivir is incorrect. Oseltamivir is an antiviral medication used to treat influenza. It is not indicated for the treatment of benign prostatic hyperplasia (BPH).
Choice B rationale
Silodosin is correct. Silodosin is an alpha-blocker used to treat the symptoms of BPH. It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.
Choice C rationale
Ceftriaxone is incorrect. Ceftriaxone is an antibiotic used to treat bacterial infections. It is not indicated for the treatment of BPH.
Choice D rationale
Doxepin is incorrect. Doxepin is a tricyclic antidepressant used to treat depression and anxiety. It is not indicated for the treatment of BPH.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.